The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands
Background: The effect of a preexisting comorbidity on the occurrence of adverse events after immunization (AEFIs) has been studied poorly. In this longitudinal cohort study, we assess the association between co-morbidities and the occurrence of AEFIs after COVID-19 vaccination. Also, we described the occurrence of flare-ups and their manifestation after COVID-19 vaccination in people with rheumatic diseases. Research design and methods: We performed multivariable logistic regression to investigate the association between the occurrence of AEFIs and 10 common comorbidities using patient-report... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2024 |
Reihe/Periodikum: | Ouaddouh , C , Duijster , J W , Lieber , T & van Hunsel , F P A M 2024 , ' The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands ' , Expert Opinion on Drug Safety , vol. 23 , no. 3 . https://doi.org/10.1080/14740338.2023.2267971 |
Schlagwörter: | adverse events / co-morbidities / COVID-19 vaccination / flare-ups / rheumatoid arthritis |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29190292 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/11be7991-13c1-42d4-8e12-a252d67f0a3b |